RenovoRx, Inc. (RNXT)
Largest Insider Buys in Sector
RNXT Stock Price History Chart
RNXT Stock Performance
About RenovoRx, Inc.
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.
Insider Activity of RenovoRx, Inc.
Over the last 12 months, insiders at RenovoRx, Inc. have bought $211,147 and sold $0 worth of RenovoRx, Inc. stock.
On average, over the past 5 years, insiders at RenovoRx, Inc. have bought $116,212 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Spiegel Robert J. (director) — $199,997. Agah Ramtin (Chief Medical Officer) — $49,999. Bagai Shaun (Chief Executive Officer) — $49,999.
The last purchase of 40,983 shares for transaction amount of $49,999 was made by Bagai Shaun (Chief Executive Officer) on 2024‑01‑26.
List of Insider Buy and Sell Transactions, RenovoRx, Inc.
| 2024-01-26 | Bagai Shaun | Chief Executive Officer | 40,983 0.4453% | $1.22 | $49,999 | +25.71% | ||
| 2024-01-26 | Agah Ramtin | Chief Medical Officer | 40,983 0.4453% | $1.22 | $49,999 | +25.71% | ||
| 2024-01-26 | Spiegel Robert J. | director | 40,983 0.4453% | $1.22 | $49,999 | +25.71% | ||
| 2024-01-26 | Macfarlane K. Angela | director | 40,983 0.4453% | $1.22 | $49,999 | +25.71% | ||
| 2024-01-26 | Marton Laurence | director | 8,196 0.0891% | $1.22 | $9,999 | +25.71% | ||
| 2023-10-03 | Nelms Angela | Chief Operating Officer | 1,100 0.0097% | $1.05 | $1,151 | +14.29% | ||
| 2022-06-07 | Agah Ramtin | Chief Medical Officer | 5,182 0.0566% | $1.93 | $10,001 | +10.26% | ||
| 2022-05-19 | Bagai Shaun | Chief Executive Officer | 5,500 0.0677% | $2.05 | $11,275 | +16.85% |
Insider Historical Profitability
| Bagai Shaun | Chief Executive Officer | 292540 2.7357% | $1.13 | 2 | 0 | +16.85% |
| Agah Ramtin | Chief Medical Officer | 47460 0.4438% | $1.13 | 2 | 0 | +10.26% |
| Spiegel Robert J. | director | 40983 0.3832% | $1.13 | 1 | 0 | |
| Macfarlane K. Angela | director | 40983 0.3832% | $1.13 | 1 | 0 | |
| Marton Laurence | director | 33634 0.3145% | $1.13 | 1 | 0 | |
| Nelms Angela | Chief Operating Officer | 1100 0.0103% | $1.13 | 1 | 0 |
Institutional Investor Ownership
No records found… | |||||||